vimarsana.com

Latest Breaking News On - Nurexone biologic ltd - Page 1 : vimarsana.com

NurExone Biologic Receives FDA Orphan-Drug Designation, Accelerating Development of ExoPTEN therapy for Acute Spinal Cord Injury Treatment

TORONTO and HAIFA, Israel, Oct. 30, 2023 (GLOBE NEWSWIRE) NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (NRX.V) (the “Company” or “NurExone”).

United-states
Israel
Germany
Canada
Toronto
Ontario
Eva-reuter
Lior-shaltiel
Company-annual-information-form
Linkedin
Israel-institute-of-technology
Company-exotherapy

NurExone Biologic Receives FDA Orphan-Drug Designation,

NurExone Biologic Receive FDA Orphan-Drug Designation to its ExoPTEN Therapy for Acute Spinal Cord Injury Treatment .

United-states
Germany
Canada
Toronto
Ontario
Israel
Eva-reuter
Lior-shaltiel
Drug-administration
Thesis-capital-inc
Nurexone-biologic-ltd
Tel-aviv-university

NurExone Biologic Announces Advancements in Extracellular Vesicles Functionality with Enhanced Potency and Cellular Uptake for potentially better drug delivery

NurExone Biologic Announces Advancements in Extracellular Vesicles Functionality with Enhanced Potency and Cellular Uptake for potentially better drug delivery
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Canada
United-states
Israel
Toronto
Ontario
Technion-haifa
Shulamit-levenberg
Inbar-paz-benayounadv
Venture-exchange
Company-sedarprofileat
Nurexone-biologic-inc
Regulation-services-provider

NurExone Biologic Inc.: Update: NurExone Biologic Successfully Demonstrates its Patent-Pending Platform Technology for Loading Exosomes with Therapeutic Molecules

Company's analysis indicates the successful achievement of its proprietary loading technology for producing exosome-based therapies NurExone is providing an updated release to the previously disseminated

Israel
Yosuke-ohtake
Lior-shaltiel
Shuxin-li
Umar-hayat
Twitter
Company-or-nurexone
Nurexone-biologic-ltd
Youtube
Library-of-medicine
Nurexone-biologic-inc
Facebook

NurExone Biologic Inc.: NurExone Announces Completion of Securities for Debt Settlements

Calgary, Alberta (Newsfile Corp. - November 8, 2022) - NurExone Biologic Inc. (TSXV: NRX) (FSE: J90) (formerly, EnerSpar Corp. or "EnerSpar") (the "Company" or "NurExone"), a biopharmaceutical company

Israel
James-jay-richardson
Lior-shaltiel
Twitter
Nurexone-biologic-ltd
Youtube
Company-on
Enerspar-corp
Nurexone-biologic-inc
Enerspar-the-company-or-nurexone
Facebook
Israel-institute-of-technology

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.